statistical product service solutions 29.0 29.0) software Search Results


99
STATA Corporation windows version 29 0
Windows Version 29 0, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+product+service+solutions+29%2E0+29%2E0)+software/STATA+2%2E0/pmc11510881-124-4-15
Average 99 stars, based on 1 article reviews
windows version 29 0 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology rpgrip1
Pedigrees of LCA families and segregation analysis of <t>RPGRIP1</t> pathologic variants. M: c.1468-128T>G; p.?, M1 c.1502-1505insTGTC; p.Ser502Valfs*7, M2 c.2895+1G>T, p?, M3 c.1525C>T, p.Gln509*, M4 c.930+77A>G, p.?, M5 c.3238+1G>A? p.?, M6 c.2437del, p.Ser813Valfs*45; +: wild-type allele. LCA: Leber congenital amaurosis, HL: hearing loss, ID: intellectual disability.
Rpgrip1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+product+service+solutions+29%2E0+29%2E0)+software/RPGRIP1+Lentiviral+Activation+Particles/pmc07922592-96-37-29
Average 92 stars, based on 1 article reviews
rpgrip1 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
Kodak edas 290 electrophoresis documentation and analysis system
Pedigrees of LCA families and segregation analysis of <t>RPGRIP1</t> pathologic variants. M: c.1468-128T>G; p.?, M1 c.1502-1505insTGTC; p.Ser502Valfs*7, M2 c.2895+1G>T, p?, M3 c.1525C>T, p.Gln509*, M4 c.930+77A>G, p.?, M5 c.3238+1G>A? p.?, M6 c.2437del, p.Ser813Valfs*45; +: wild-type allele. LCA: Leber congenital amaurosis, HL: hearing loss, ID: intellectual disability.
Edas 290 Electrophoresis Documentation And Analysis System, supplied by Kodak, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+product+service+solutions+29%2E0+29%2E0)+software/edas+290+system/pmc03523536-69-7-9
Average 90 stars, based on 1 article reviews
edas 290 electrophoresis documentation and analysis system - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

99
Synoptics Ltd genetools analysis software
Pedigrees of LCA families and segregation analysis of <t>RPGRIP1</t> pathologic variants. M: c.1468-128T>G; p.?, M1 c.1502-1505insTGTC; p.Ser502Valfs*7, M2 c.2895+1G>T, p?, M3 c.1525C>T, p.Gln509*, M4 c.930+77A>G, p.?, M5 c.3238+1G>A? p.?, M6 c.2437del, p.Ser813Valfs*45; +: wild-type allele. LCA: Leber congenital amaurosis, HL: hearing loss, ID: intellectual disability.
Genetools Analysis Software, supplied by Synoptics Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+product+service+solutions+29%2E0+29%2E0)+software/GeneTools/pmc08248818-46-15-20
Average 99 stars, based on 1 article reviews
genetools analysis software - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

90
MedCalc Software Ltd medcalc version 20.2
Pedigrees of LCA families and segregation analysis of <t>RPGRIP1</t> pathologic variants. M: c.1468-128T>G; p.?, M1 c.1502-1505insTGTC; p.Ser502Valfs*7, M2 c.2895+1G>T, p?, M3 c.1525C>T, p.Gln509*, M4 c.930+77A>G, p.?, M5 c.3238+1G>A? p.?, M6 c.2437del, p.Ser813Valfs*45; +: wild-type allele. LCA: Leber congenital amaurosis, HL: hearing loss, ID: intellectual disability.
Medcalc Version 20.2, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+product+service+solutions+29%2E0+29%2E0)+software/medcalc+9+0+1/pm40328542-79-5-16
Average 90 stars, based on 1 article reviews
medcalc version 20.2 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd medcalc 29.0.0
Pedigrees of LCA families and segregation analysis of <t>RPGRIP1</t> pathologic variants. M: c.1468-128T>G; p.?, M1 c.1502-1505insTGTC; p.Ser502Valfs*7, M2 c.2895+1G>T, p?, M3 c.1525C>T, p.Gln509*, M4 c.930+77A>G, p.?, M5 c.3238+1G>A? p.?, M6 c.2437del, p.Ser813Valfs*45; +: wild-type allele. LCA: Leber congenital amaurosis, HL: hearing loss, ID: intellectual disability.
Medcalc 29.0.0, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+product+service+solutions+29%2E0+29%2E0)+software/medcalc+29+0+0/pm39250610-49-7-7
Average 90 stars, based on 1 article reviews
medcalc 29.0.0 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Kraton Corporation paraffin wax
Pedigrees of LCA families and segregation analysis of <t>RPGRIP1</t> pathologic variants. M: c.1468-128T>G; p.?, M1 c.1502-1505insTGTC; p.Ser502Valfs*7, M2 c.2895+1G>T, p?, M3 c.1525C>T, p.Gln509*, M4 c.930+77A>G, p.?, M5 c.3238+1G>A? p.?, M6 c.2437del, p.Ser813Valfs*45; +: wild-type allele. LCA: Leber congenital amaurosis, HL: hearing loss, ID: intellectual disability.
Paraffin Wax, supplied by Kraton Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+product+service+solutions+29%2E0+29%2E0)+software/paraffin+wax/us09783712-309-28-74
Average 90 stars, based on 1 article reviews
paraffin wax - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Mycogen Inc 2p172
Pedigrees of LCA families and segregation analysis of <t>RPGRIP1</t> pathologic variants. M: c.1468-128T>G; p.?, M1 c.1502-1505insTGTC; p.Ser502Valfs*7, M2 c.2895+1G>T, p?, M3 c.1525C>T, p.Gln509*, M4 c.930+77A>G, p.?, M5 c.3238+1G>A? p.?, M6 c.2437del, p.Ser813Valfs*45; +: wild-type allele. LCA: Leber congenital amaurosis, HL: hearing loss, ID: intellectual disability.
2p172, supplied by Mycogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+product+service+solutions+29%2E0+29%2E0)+software/2p172/us08822777-277-70-112
Average 90 stars, based on 1 article reviews
2p172 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
BioNTech bnt162b2
Characteristics and Outcomes of the Included Studies
Bnt162b2, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+product+service+solutions+29%2E0+29%2E0)+software/bnt162b2/pmc08479970-18-57-58
Average 90 stars, based on 1 article reviews
bnt162b2 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
NCIMB Ltd gt50 dark ncimb 41919
Characteristics and Outcomes of the Included Studies
Gt50 Dark Ncimb 41919, supplied by NCIMB Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+product+service+solutions+29%2E0+29%2E0)+software/gt50+dark+ncimb+41919/us09351473-235-37-41
Average 90 stars, based on 1 article reviews
gt50 dark ncimb 41919 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

mbcp 2  (BASF)
90
BASF mbcp 2
Gel permeation chromatograms of (a) <t>MBCP-1,</t> <t>(b)</t> <t>Pluronic®</t> P85, (c) MBCP-2 and (d) Pluronic® P104. The retention times of the synthesized polymers (~8.1) were different from the Pluronic® copolymers (~9.2) indicating the formation of MBCPs.
Mbcp 2, supplied by BASF, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+product+service+solutions+29%2E0+29%2E0)+software/mbcp+2/pmc02818050-285-45-82
Average 90 stars, based on 1 article reviews
mbcp 2 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
LEAD Technologies spss 29.0
Gel permeation chromatograms of (a) <t>MBCP-1,</t> <t>(b)</t> <t>Pluronic®</t> P85, (c) MBCP-2 and (d) Pluronic® P104. The retention times of the synthesized polymers (~8.1) were different from the Pluronic® copolymers (~9.2) indicating the formation of MBCPs.
Spss 29.0, supplied by LEAD Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+product+service+solutions+29%2E0+29%2E0)+software/spss+17+0+software+package/pm39852771-54-5-7
Average 90 stars, based on 1 article reviews
spss 29.0 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Pedigrees of LCA families and segregation analysis of RPGRIP1 pathologic variants. M: c.1468-128T>G; p.?, M1 c.1502-1505insTGTC; p.Ser502Valfs*7, M2 c.2895+1G>T, p?, M3 c.1525C>T, p.Gln509*, M4 c.930+77A>G, p.?, M5 c.3238+1G>A? p.?, M6 c.2437del, p.Ser813Valfs*45; +: wild-type allele. LCA: Leber congenital amaurosis, HL: hearing loss, ID: intellectual disability.

Journal: Genes

Article Title: Whole Locus Sequencing Identifies a Prevalent Founder Deep Intronic RPGRIP1 Pathologic Variant in the French Leber Congenital Amaurosis Cohort

doi: 10.3390/genes12020287

Figure Lengend Snippet: Pedigrees of LCA families and segregation analysis of RPGRIP1 pathologic variants. M: c.1468-128T>G; p.?, M1 c.1502-1505insTGTC; p.Ser502Valfs*7, M2 c.2895+1G>T, p?, M3 c.1525C>T, p.Gln509*, M4 c.930+77A>G, p.?, M5 c.3238+1G>A? p.?, M6 c.2437del, p.Ser813Valfs*45; +: wild-type allele. LCA: Leber congenital amaurosis, HL: hearing loss, ID: intellectual disability.

Article Snippet: The position of the markers (locus name and position in parentheses) and of the mutation were estimated from the human genome GRCh37/hg19 assembly available from the University of California, Santa Cruz (UCSC): AFM199ZF4 (D14S72: 21,370,988–21,371,351)—AFMB329WE5 (D14S1023: 21,441,901–21,442,220)— RPGRIP1 (c.1468-128G>T: 21,789,290)—AFMA086WB5(D14S1070: 21,548,252–21,548,590)—CHLC.GATA74E02 (D14S742: 22,200,886–22,201,487)—AFM312XH1 (D14S283: 22,687,415–22,687,784).

Techniques:

 RPGRIP1  variants and clinical characteristics of the patients with Leber congenital amaurosis (LCA) included in the present study. LP: light perception, RLE: right left eye, ERG: electroretinogram, na: not available.

Journal: Genes

Article Title: Whole Locus Sequencing Identifies a Prevalent Founder Deep Intronic RPGRIP1 Pathologic Variant in the French Leber Congenital Amaurosis Cohort

doi: 10.3390/genes12020287

Figure Lengend Snippet: RPGRIP1 variants and clinical characteristics of the patients with Leber congenital amaurosis (LCA) included in the present study. LP: light perception, RLE: right left eye, ERG: electroretinogram, na: not available.

Article Snippet: The position of the markers (locus name and position in parentheses) and of the mutation were estimated from the human genome GRCh37/hg19 assembly available from the University of California, Santa Cruz (UCSC): AFM199ZF4 (D14S72: 21,370,988–21,371,351)—AFMB329WE5 (D14S1023: 21,441,901–21,442,220)— RPGRIP1 (c.1468-128G>T: 21,789,290)—AFMA086WB5(D14S1070: 21,548,252–21,548,590)—CHLC.GATA74E02 (D14S742: 22,200,886–22,201,487)—AFM312XH1 (D14S283: 22,687,415–22,687,784).

Techniques: Biomarker Discovery, Transmission Assay

Splicing prediction scores around the RPGRIP1 c.1468-128T>G variant in intron 11, position and sequence of the pseudo-exon amplified from patient mRNA and position of splice-switching antisense oligonucleotides (AONs). ( A ) Representation of the intron 11 region encompassing the c.1468-128T>G variant and cryptic acceptor and donor splice-sites with splicing score predictions according to the Alamut Software. The pseudo-exon (PE) is framed in red. The sequences of the three AONs designed to target the cryptic acceptor splice site (AON1), one exonic splice enhancer (ESE) sequence in the cryptic exon (AON2) and the cryptic donor splice site (AON3) designed using the ESEFinder 3.0 program are framed in black.( B ) Schematic representation of wild-type and mutant RPGRIP1 mRNAs produced from the c.1468-128T>G mutant allele in both homozygous and heterozygous individuals and sequence of the mutant mRNA encompassing the pseudo-exon (PE, framed in red) between exons 11 and 12. ( C ) RT-PCR from mRNA isolated from controls (C1, C2) and patients carrying the c.1468-128T>G variant in homozygosity (LCA426) and compound heterozygosity (MON035, LCA215) in native condition and following treatment of C1, C2 and LCA215 lymphoblasts with 150 nmoL/L of AON1, AON2, AON3 or AONsense. In native conditions, RT-PCR from mRNA extracted from LCA426 and MON035 fibroblasts and LCA215 lymphoblasts yielded two products, the wildtype product (exon 11–12: 194 bp) and a higher molecular weight fragment (exon 11-PE-12: 312 bp). The controls C1 and C2 only display the wildtype 194-bp product. The treatment of LCA215 lymphoblasts with AON1, AON2, or AON3, but not the negative control sense oligonucleotide (AONsense), resulted in the disappearance of the higher molecular weight product encompassing the aberrant pseudo-exon.

Journal: Genes

Article Title: Whole Locus Sequencing Identifies a Prevalent Founder Deep Intronic RPGRIP1 Pathologic Variant in the French Leber Congenital Amaurosis Cohort

doi: 10.3390/genes12020287

Figure Lengend Snippet: Splicing prediction scores around the RPGRIP1 c.1468-128T>G variant in intron 11, position and sequence of the pseudo-exon amplified from patient mRNA and position of splice-switching antisense oligonucleotides (AONs). ( A ) Representation of the intron 11 region encompassing the c.1468-128T>G variant and cryptic acceptor and donor splice-sites with splicing score predictions according to the Alamut Software. The pseudo-exon (PE) is framed in red. The sequences of the three AONs designed to target the cryptic acceptor splice site (AON1), one exonic splice enhancer (ESE) sequence in the cryptic exon (AON2) and the cryptic donor splice site (AON3) designed using the ESEFinder 3.0 program are framed in black.( B ) Schematic representation of wild-type and mutant RPGRIP1 mRNAs produced from the c.1468-128T>G mutant allele in both homozygous and heterozygous individuals and sequence of the mutant mRNA encompassing the pseudo-exon (PE, framed in red) between exons 11 and 12. ( C ) RT-PCR from mRNA isolated from controls (C1, C2) and patients carrying the c.1468-128T>G variant in homozygosity (LCA426) and compound heterozygosity (MON035, LCA215) in native condition and following treatment of C1, C2 and LCA215 lymphoblasts with 150 nmoL/L of AON1, AON2, AON3 or AONsense. In native conditions, RT-PCR from mRNA extracted from LCA426 and MON035 fibroblasts and LCA215 lymphoblasts yielded two products, the wildtype product (exon 11–12: 194 bp) and a higher molecular weight fragment (exon 11-PE-12: 312 bp). The controls C1 and C2 only display the wildtype 194-bp product. The treatment of LCA215 lymphoblasts with AON1, AON2, or AON3, but not the negative control sense oligonucleotide (AONsense), resulted in the disappearance of the higher molecular weight product encompassing the aberrant pseudo-exon.

Article Snippet: The position of the markers (locus name and position in parentheses) and of the mutation were estimated from the human genome GRCh37/hg19 assembly available from the University of California, Santa Cruz (UCSC): AFM199ZF4 (D14S72: 21,370,988–21,371,351)—AFMB329WE5 (D14S1023: 21,441,901–21,442,220)— RPGRIP1 (c.1468-128G>T: 21,789,290)—AFMA086WB5(D14S1070: 21,548,252–21,548,590)—CHLC.GATA74E02 (D14S742: 22,200,886–22,201,487)—AFM312XH1 (D14S283: 22,687,415–22,687,784).

Techniques: Variant Assay, Sequencing, Amplification, Software, Mutagenesis, Produced, Reverse Transcription Polymerase Chain Reaction, Isolation, Molecular Weight, Negative Control

Linkage analysis of the  RPGRIP1  region using microsatellites D14S72, D14S1023,  D14S1070,  D14S742 and D14S283 in four independent families harbouring the c.1468-128T> G. The common haplotype is in red.

Journal: Genes

Article Title: Whole Locus Sequencing Identifies a Prevalent Founder Deep Intronic RPGRIP1 Pathologic Variant in the French Leber Congenital Amaurosis Cohort

doi: 10.3390/genes12020287

Figure Lengend Snippet: Linkage analysis of the RPGRIP1 region using microsatellites D14S72, D14S1023, D14S1070, D14S742 and D14S283 in four independent families harbouring the c.1468-128T> G. The common haplotype is in red.

Article Snippet: The position of the markers (locus name and position in parentheses) and of the mutation were estimated from the human genome GRCh37/hg19 assembly available from the University of California, Santa Cruz (UCSC): AFM199ZF4 (D14S72: 21,370,988–21,371,351)—AFMB329WE5 (D14S1023: 21,441,901–21,442,220)— RPGRIP1 (c.1468-128G>T: 21,789,290)—AFMA086WB5(D14S1070: 21,548,252–21,548,590)—CHLC.GATA74E02 (D14S742: 22,200,886–22,201,487)—AFM312XH1 (D14S283: 22,687,415–22,687,784).

Techniques: Mutagenesis

Characteristics and Outcomes of the Included Studies

Journal: Gastroenterology

Article Title: Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis

doi: 10.1053/j.gastro.2021.09.055

Figure Lengend Snippet: Characteristics and Outcomes of the Included Studies

Article Snippet: Ruddy , United States , 2021 Letter , 404 (inflammatory diseases 44.6%, SLE 21.5%, Sjögren’s syndrome 4.7%, myositis 5.9%, SSc 0.5%, vasculitis 2.0%, overlap connective tissue disease 20.8%) , None , 44 (IQR 36–57) , 95.3% , 100% (hydroxychloroquine 42.1%, MTX 23.3%, TNFi 24.3%, belimumab 13.9%, mycophenolate 10.1%, AZA 8.7%, IL inhibitors 7.7%, etc) , 29.0% , BNT162b2 (Pfizer-BioNTech) 49.0%, mRNA-1273 (Moderna) 51.0% , 0 , 404.

Techniques: Control, Vaccines

Gel permeation chromatograms of (a) MBCP-1, (b) Pluronic® P85, (c) MBCP-2 and (d) Pluronic® P104. The retention times of the synthesized polymers (~8.1) were different from the Pluronic® copolymers (~9.2) indicating the formation of MBCPs.

Journal:

Article Title: A NOVEL THERMOSENSITIVE POLYMER WITH pH-DEPENDENT DEGRADATION FOR DRUG DELIVERY

doi: 10.1016/j.actbio.2009.07.005

Figure Lengend Snippet: Gel permeation chromatograms of (a) MBCP-1, (b) Pluronic® P85, (c) MBCP-2 and (d) Pluronic® P104. The retention times of the synthesized polymers (~8.1) were different from the Pluronic® copolymers (~9.2) indicating the formation of MBCPs.

Article Snippet: Polymer M n (g/mol) a M w /M n b Number of repeating units T m (°C) c Pluronic® P85 7440 (±130) (4600 d ) 1.04 - 38.9 Pluronic® P104 9880 (±170) (5900 e ) 1.04 - 39.4 MBCP 1 36920 (±1650) 1.66 4.9 29.0 MBCP 2 40210 (± 860) 1.69 4.1 29.8 Open in a separate window a Number average molecular weights determined by GPC b Polydispersities based on GPC measurements c Melting temperatures determined by DSC d,e Molecular weights from BASF chemical company Characterization results of the synthesized MBCPs.

Techniques: Synthesized

Characterization results of the synthesized MBCPs. The Number average molecular weights represent the mean ± SD for n=3.

Journal:

Article Title: A NOVEL THERMOSENSITIVE POLYMER WITH pH-DEPENDENT DEGRADATION FOR DRUG DELIVERY

doi: 10.1016/j.actbio.2009.07.005

Figure Lengend Snippet: Characterization results of the synthesized MBCPs. The Number average molecular weights represent the mean ± SD for n=3.

Article Snippet: Polymer M n (g/mol) a M w /M n b Number of repeating units T m (°C) c Pluronic® P85 7440 (±130) (4600 d ) 1.04 - 38.9 Pluronic® P104 9880 (±170) (5900 e ) 1.04 - 39.4 MBCP 1 36920 (±1650) 1.66 4.9 29.0 MBCP 2 40210 (± 860) 1.69 4.1 29.8 Open in a separate window a Number average molecular weights determined by GPC b Polydispersities based on GPC measurements c Melting temperatures determined by DSC d,e Molecular weights from BASF chemical company Characterization results of the synthesized MBCPs.

Techniques: Synthesized

Phase diagrams of the aqueous solutions of Pluronic® P85, Pluronic® P104, MBCP-1 and MBCP-2 determined by the test tube inverting method.

Journal:

Article Title: A NOVEL THERMOSENSITIVE POLYMER WITH pH-DEPENDENT DEGRADATION FOR DRUG DELIVERY

doi: 10.1016/j.actbio.2009.07.005

Figure Lengend Snippet: Phase diagrams of the aqueous solutions of Pluronic® P85, Pluronic® P104, MBCP-1 and MBCP-2 determined by the test tube inverting method.

Article Snippet: Polymer M n (g/mol) a M w /M n b Number of repeating units T m (°C) c Pluronic® P85 7440 (±130) (4600 d ) 1.04 - 38.9 Pluronic® P104 9880 (±170) (5900 e ) 1.04 - 39.4 MBCP 1 36920 (±1650) 1.66 4.9 29.0 MBCP 2 40210 (± 860) 1.69 4.1 29.8 Open in a separate window a Number average molecular weights determined by GPC b Polydispersities based on GPC measurements c Melting temperatures determined by DSC d,e Molecular weights from BASF chemical company Characterization results of the synthesized MBCPs.

Techniques: